Maryland Lawmakers File Bills To Extend Psychedelics Task Force To Recommend More Reforms Through 2027
Maryland Lawmakers Propose Extension for Psychedelics Task Force
Maryland lawmakers have filed bills to extend a psychedelic task force through the end of 2027 to develop updated recommendations on expanding therapeutic access to the novel drugs and potentially creating a regulatory framework for broader legalization.
Sen. Brian Feldman (D) and Del. Pam Guzzone (D) last week introduced companion versions of the legislation for the 2026 session, aiming to build upon a current law that created the Maryland Task Force on Responsible Use of Natural Psychedelic Substances.
Key Findings and Recommendations
That panel released an initial final report to state lawmakers last year, with recommendations for the phased implementation of a wide range of reforms to provide legal therapeutic access to substances such as psilocybin. Members advised that it was ultimately recommending a “multi-pathway framework for safe, broad, and equitable access to natural psychedelic substances, with an initial focus on psilocybin.”
Oversight and Timeline
The psychedelics task force was formed following Gov. Wes Moore’s (D) signing of a pair of bills into law in 2024. The 17-person body, overseen by the Maryland Cannabis Administration (MCA), was charged with studying how to ensure “broad, equitable and affordable access to psychedelic substances” in the state.
Now, both the House and Senate have new proposals that would continue that work:
Extension: Maintains the panel through December 31, 2027.
Reporting: Requires an updated report to legislators with additional findings by October 31, 2026.
Next Steps: The House bill is scheduled for a hearing before the Health Committee on February 10.
